# Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance

> **NCT01664845** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Hepatitis c
- Insulin Resistance

## Interventions

- **DRUG:** metformin
- **DRUG:** pegylated-IFN
- **DRUG:** ribavirin

## Key facts

- **NCT ID:** NCT01664845
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664845, "Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01664845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*